Evaluation of urinary neutrophil gelatinase‐associated lipocalin to detect renal tubular damage in dogs with stable myxomatous mitral valve disease

Abstract Background Dogs with myxomatous mitral valve disease (MMVD) can experience progressive renal tubular damage and dysfunction. The prevalence of renal tubular damage is not known in dogs with stable MMVD. Objective To evaluate renal tubular damage in dogs with stable MMVD by evaluation of uri...

Full description

Bibliographic Details
Main Authors: Roberta Troia, Maria Chiara Sabetti, Serena Crosara, Cecilia Quintavalla, Giovanni Romito, Chiara Mazzoldi, Francesca Fidanzio, Maura Cescatti, Walter Bertazzolo, Massimo Giunti, Francesco Dondi
Format: Article
Language:English
Published: Wiley 2022-11-01
Series:Journal of Veterinary Internal Medicine
Subjects:
Online Access:https://doi.org/10.1111/jvim.16503
_version_ 1797976836556193792
author Roberta Troia
Maria Chiara Sabetti
Serena Crosara
Cecilia Quintavalla
Giovanni Romito
Chiara Mazzoldi
Francesca Fidanzio
Maura Cescatti
Walter Bertazzolo
Massimo Giunti
Francesco Dondi
author_facet Roberta Troia
Maria Chiara Sabetti
Serena Crosara
Cecilia Quintavalla
Giovanni Romito
Chiara Mazzoldi
Francesca Fidanzio
Maura Cescatti
Walter Bertazzolo
Massimo Giunti
Francesco Dondi
author_sort Roberta Troia
collection DOAJ
description Abstract Background Dogs with myxomatous mitral valve disease (MMVD) can experience progressive renal tubular damage and dysfunction. The prevalence of renal tubular damage is not known in dogs with stable MMVD. Objective To evaluate renal tubular damage in dogs with stable MMVD by evaluation of urinary neutrophil gelatinase‐associated lipocalin (NGAL). Animals Ninety‐eight MMVD dogs grouped according to the American College of Veterinary Internal Medicine (ACVIM) staging (group B1, n = 23; group B2, n = 27; group C + D, n = 48) and 46 healthy dogs. Methods Multicenter prospective observational study. Serum and urine chemistry including NGAL reported as uNGAL concentration (uNGAL) and normalized with urinary creatinine (uNGALC) were compared between MMVD dogs and healthy controls, and among different MMVD ACVIM stages. Results The MMVD dogs had significantly higher uNGAL and uNGALC (1204 pg/mL; range, 30‐39 732 and 1816 pg/mg; range, 22‐127 693, respectively) compared to healthy dogs (584 pg/mL; range, 56‐4072 and 231 pg/mg; range, 15‐2407, respectively; P = .002 and P < .0001, respectively). Both uNGAL and uNGALC increased with the increasing ACVIM stage (P = .001 and P < .001, respectively). Conclusions and Clinical Importance Renal tubular damage is present in dogs with stable MMVD, as measured by increased uNGAL. This tubular damage is subclinical, occurs in all stages of MMVD even in the absence of azotemia, and increases with the severity of MMVD. Reno‐protective approaches to manage MMVD dogs should be explored to slow the progression of renal tubular damage in these patients.
first_indexed 2024-04-11T04:57:19Z
format Article
id doaj.art-2119baf2733841b886afd6be8d1d4f99
institution Directory Open Access Journal
issn 0891-6640
1939-1676
language English
last_indexed 2024-04-11T04:57:19Z
publishDate 2022-11-01
publisher Wiley
record_format Article
series Journal of Veterinary Internal Medicine
spelling doaj.art-2119baf2733841b886afd6be8d1d4f992022-12-26T07:32:23ZengWileyJournal of Veterinary Internal Medicine0891-66401939-16762022-11-013662053206210.1111/jvim.16503Evaluation of urinary neutrophil gelatinase‐associated lipocalin to detect renal tubular damage in dogs with stable myxomatous mitral valve diseaseRoberta Troia0Maria Chiara Sabetti1Serena Crosara2Cecilia Quintavalla3Giovanni Romito4Chiara Mazzoldi5Francesca Fidanzio6Maura Cescatti7Walter Bertazzolo8Massimo Giunti9Francesco Dondi10Department of Veterinary Medical Sciences Alma Mater Studiorum—University of Bologna Bologna ItalyDepartment of Veterinary Medical Sciences Alma Mater Studiorum—University of Bologna Bologna ItalyDepartment of Veterinary Sciences University of Parma Parma ItalyDepartment of Veterinary Sciences University of Parma Parma ItalyDepartment of Veterinary Medical Sciences Alma Mater Studiorum—University of Bologna Bologna ItalyDepartment of Veterinary Medical Sciences Alma Mater Studiorum—University of Bologna Bologna ItalyDepartment of Veterinary Sciences University of Parma Parma ItalyFondazione IRET Bologna ItalyMylav‐Laboratorio La Vallonea Milan ItalyDepartment of Veterinary Medical Sciences Alma Mater Studiorum—University of Bologna Bologna ItalyDepartment of Veterinary Medical Sciences Alma Mater Studiorum—University of Bologna Bologna ItalyAbstract Background Dogs with myxomatous mitral valve disease (MMVD) can experience progressive renal tubular damage and dysfunction. The prevalence of renal tubular damage is not known in dogs with stable MMVD. Objective To evaluate renal tubular damage in dogs with stable MMVD by evaluation of urinary neutrophil gelatinase‐associated lipocalin (NGAL). Animals Ninety‐eight MMVD dogs grouped according to the American College of Veterinary Internal Medicine (ACVIM) staging (group B1, n = 23; group B2, n = 27; group C + D, n = 48) and 46 healthy dogs. Methods Multicenter prospective observational study. Serum and urine chemistry including NGAL reported as uNGAL concentration (uNGAL) and normalized with urinary creatinine (uNGALC) were compared between MMVD dogs and healthy controls, and among different MMVD ACVIM stages. Results The MMVD dogs had significantly higher uNGAL and uNGALC (1204 pg/mL; range, 30‐39 732 and 1816 pg/mg; range, 22‐127 693, respectively) compared to healthy dogs (584 pg/mL; range, 56‐4072 and 231 pg/mg; range, 15‐2407, respectively; P = .002 and P < .0001, respectively). Both uNGAL and uNGALC increased with the increasing ACVIM stage (P = .001 and P < .001, respectively). Conclusions and Clinical Importance Renal tubular damage is present in dogs with stable MMVD, as measured by increased uNGAL. This tubular damage is subclinical, occurs in all stages of MMVD even in the absence of azotemia, and increases with the severity of MMVD. Reno‐protective approaches to manage MMVD dogs should be explored to slow the progression of renal tubular damage in these patients.https://doi.org/10.1111/jvim.16503acute kidney injurycardiorenal syndromeheart failurerenal biomarkertubular damage
spellingShingle Roberta Troia
Maria Chiara Sabetti
Serena Crosara
Cecilia Quintavalla
Giovanni Romito
Chiara Mazzoldi
Francesca Fidanzio
Maura Cescatti
Walter Bertazzolo
Massimo Giunti
Francesco Dondi
Evaluation of urinary neutrophil gelatinase‐associated lipocalin to detect renal tubular damage in dogs with stable myxomatous mitral valve disease
Journal of Veterinary Internal Medicine
acute kidney injury
cardiorenal syndrome
heart failure
renal biomarker
tubular damage
title Evaluation of urinary neutrophil gelatinase‐associated lipocalin to detect renal tubular damage in dogs with stable myxomatous mitral valve disease
title_full Evaluation of urinary neutrophil gelatinase‐associated lipocalin to detect renal tubular damage in dogs with stable myxomatous mitral valve disease
title_fullStr Evaluation of urinary neutrophil gelatinase‐associated lipocalin to detect renal tubular damage in dogs with stable myxomatous mitral valve disease
title_full_unstemmed Evaluation of urinary neutrophil gelatinase‐associated lipocalin to detect renal tubular damage in dogs with stable myxomatous mitral valve disease
title_short Evaluation of urinary neutrophil gelatinase‐associated lipocalin to detect renal tubular damage in dogs with stable myxomatous mitral valve disease
title_sort evaluation of urinary neutrophil gelatinase associated lipocalin to detect renal tubular damage in dogs with stable myxomatous mitral valve disease
topic acute kidney injury
cardiorenal syndrome
heart failure
renal biomarker
tubular damage
url https://doi.org/10.1111/jvim.16503
work_keys_str_mv AT robertatroia evaluationofurinaryneutrophilgelatinaseassociatedlipocalintodetectrenaltubulardamageindogswithstablemyxomatousmitralvalvedisease
AT mariachiarasabetti evaluationofurinaryneutrophilgelatinaseassociatedlipocalintodetectrenaltubulardamageindogswithstablemyxomatousmitralvalvedisease
AT serenacrosara evaluationofurinaryneutrophilgelatinaseassociatedlipocalintodetectrenaltubulardamageindogswithstablemyxomatousmitralvalvedisease
AT ceciliaquintavalla evaluationofurinaryneutrophilgelatinaseassociatedlipocalintodetectrenaltubulardamageindogswithstablemyxomatousmitralvalvedisease
AT giovanniromito evaluationofurinaryneutrophilgelatinaseassociatedlipocalintodetectrenaltubulardamageindogswithstablemyxomatousmitralvalvedisease
AT chiaramazzoldi evaluationofurinaryneutrophilgelatinaseassociatedlipocalintodetectrenaltubulardamageindogswithstablemyxomatousmitralvalvedisease
AT francescafidanzio evaluationofurinaryneutrophilgelatinaseassociatedlipocalintodetectrenaltubulardamageindogswithstablemyxomatousmitralvalvedisease
AT mauracescatti evaluationofurinaryneutrophilgelatinaseassociatedlipocalintodetectrenaltubulardamageindogswithstablemyxomatousmitralvalvedisease
AT walterbertazzolo evaluationofurinaryneutrophilgelatinaseassociatedlipocalintodetectrenaltubulardamageindogswithstablemyxomatousmitralvalvedisease
AT massimogiunti evaluationofurinaryneutrophilgelatinaseassociatedlipocalintodetectrenaltubulardamageindogswithstablemyxomatousmitralvalvedisease
AT francescodondi evaluationofurinaryneutrophilgelatinaseassociatedlipocalintodetectrenaltubulardamageindogswithstablemyxomatousmitralvalvedisease